Qlaris Bio
Series B
Therapy for ophthalmic diseases
Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.
Founders
B
LinkedIn ↗
Similar Startups
OpenEvidence
Series D
Organizing the world’s medical knowledge
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Freenome
Blood test to detect colorectal cancer
Mira
Hormone monitor and supplements
Janux Therapeutics
Immunotherapy to fight tumors
Epikast
Series B
Engage patients and health providers